Atherosclerosis
Volume 212, Issue 2 , Pages 481-487 , October 2010

Interactions between age and apoE genotype on fasting and postprandial triglycerides levels

  • Andrew L. Carvalho-Wells

      Affiliations

    • Department of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6AP, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 118 3786394; fax: +44 118 9310080.
    • ,
  • Kim G. Jackson

      Affiliations

    • Department of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6AP, UK
    • ,
  • Rosalynn Gill

      Affiliations

    • Ipsogen, Inc, 700 Canal Street, CT 06902, USA
    • ,
  • Estibaliz Olano-Martin

      Affiliations

    • Department of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6AP, UK
    • ,
  • Julie A. Lovegrove

      Affiliations

    • Department of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6AP, UK
    • ,
  • Christine M. Williams

      Affiliations

    • Department of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6AP, UK
    • ,
  • Anne M. Minihane

      Affiliations

    • Department of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6AP, UK
    • Present address: Diet and Health Group, School of Medicine, University of East Anglia, Norwich, NR4 7TJ, UK.

Received 8 January 2010 ,Revised 3 June 2010 ,Accepted 18 June 2010.

References 

  1. Bouchier IAD, Bronte-Stewart B. Alimentary lipemia and ischaemic heart disease. Lancet. 1961;277:363–366
  2. Groot PHE, Vanstiphout W, Krauss XH, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb. 1991;11:653–662
  3. Patsch JR, Miesenbock G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary artery disease-studies in the postprandial state. Arterioscler Thromb. 1992;12:1336–1345
  4. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299–308
  5. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309–316
  6. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000;86:943–949
  7. Austin MA. Triacylglycerol and coronary heart disease. Proc Nutr Soc. 1997;56:667–670
  8. Roche HM, Gibney MJ. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism1. Am J Clin Nutr. 2000;71:232–237
  9. Lopez-Miranda J, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr. 2007;98:458–473
  10. Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F, Ordovas JM. Influence of genetic factors in the modulation of postprandial lipemia. Atheroscler Suppl. 2008;9:49–55
  11. Mahley RW. Apolipoprotein E-cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622–630
  12. Weisgraber KH. Apolipoprotein E: structure–function relationships. Advances in protein chemistry, vol. 45. San Diego: Academic Press Inc.; 1994;p. 249–302
  13. Tetali SD, Budamagunta MS, Voss JC, Rutledge JC. C-terminal interactions of apolipoprotein E4 respond to the postprandial state. J Lipid Res. 2006;47:1358–1365
  14. Miettinen TA, Gylling H, Vanhanen H, Ollus A. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb. 1992;12:1044–1052
  15. Minihane AM, Jofre-Monseny L, Olano-Martin E, Rimbach G. ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proc Nutr Soc. 2007;66:183–197
  16. Huang YD, Ji ZS, Brecht WJ, Rall SC, Taylor JM, Mahley RW. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis. Arterioscler Thromb Vasc Biol. 1999;19:2952–2959
  17. Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet. 1994;54:341–360
  18. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clinical Invest. 1987;80:1571–1577
  19. Rimbach G, Minihane AM. Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there?. Proc Nutr Soc. 2009;68:162–172
  20. Olano-Martin E, Abraham EC, Gill-Garrison R, et al. Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender. J Lipid Res. 2008;49:945–953
  21. McNamara JR, Huang C, Massov T, et al. Modification of the dextran–Mg2+ high density lipoprotein cholesterol precipitation method for use with previously frozen plasma. Clin Chem. 1994;40:233–239
  22. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J. Rapid isolation of low-density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis. 1990;83:59–67
  23. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clinical Chem. 1972;18:499–502
  24. Frayn KN. Metabolic regulation: a human perspective. 2nd ed.. Oxford: Portland Press; 2003;
  25. Frayn KN, Summers LKM, Fielding BA. Regulation of the plasma non-esterified fatty acid concentration in the postprandial state. Proc Nutr Soc. 1997;56:713–721
  26. Bennet AM, Di Angelantonio E, Ye Z, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007;298:1300–1311
  27. Caslake MJ, Miles EA, Kofler BM, et al. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr. 2008;88:618–629
  28. Skoglund-Andersson C, Ehrenborg E, Fisher RM, Olivercrona G, Hamsten A, Karpe F. Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men. Atherosclerosis. 2003;167:311–317
  29. Lipoprotein atherogenicity: an overview of current mechanisms. In:  Griffin BA editors. Meeting of the Nutrition-Society. Guildford, England, June 29–July 2. 1999;
  30. Mahley RW, Huang YD, Rall SC. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes. J Lipid Res. 1999;40:1933–1949
  31. Minihane AM, Khan S, Leigh-Firbank EC, et al. ApoE polymorphism and fish oil supplementation in subjects with an antherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol. 2000;20:1990–1997
  32. Dart A, Sherrard B, Simpson H. Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease. Atherosclerosis. 1997;130:161–170
  33. Dart AM, Cooper B. Independent effects of Apo E phenotype and plasma triglyceride on lipoprotein particle sizes in the fasting and postprandial states. Arterioscler Thromb Vasc Biol. 1999;19:2465–2473
  34. Kobayashi J, Saito Y, Taira K, et al. Effect of apolipoprotein E3/4 phenotype on postprandial triglycerides and retinyl palmitate metabolism in plasma from hyperlipidemic subjects in Japan. Atherosclerosis. 2001;154:539–546
  35. Dallongeville J, Tiret L, Visvikis S, et al. Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. Atherosclerosis. 1999;145:381–388
  36. Huang Y, Liu XQ, Rall SC, et al. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem. 1998;273:26388–26393
  37. Rensen PCN, van Berkel TJC. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem. 1996;271:14791–14799
  38. Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest. 1986;78:815–821
  39. Heeren J, Beisiegel U, Grewal T. Apolipoprotein E recycling implications for dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:442–448
  40. Heeren J, Grewal T, Laatsch A, et al. Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J Biol Chem. 2004;279:55483–55492
  41. Fazio S, Major AS, Swift LL, et al. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J Clin Invest. 2001;107:163–171
  42. Reznik Y, Morello R, Pousse P, Mahoudeau J, Fradin S. The effect of age, body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin-dependent diabetes mellitus. Metabolism. 2002;51:1088–1092
  43. Stiefel P, Montilla C, Muniz-Grijalvo O, et al. Apolipoprotein E gene polymorphism is related to metabolic abnormalities, but does not influence erythrocyte membrane lipid composition or sodium-lithium countertransport activity in essential hypertension. Metabolism. 2001;50:157–160

PII: S0021-9150(10)00492-2

doi: 10.1016/j.atherosclerosis.2010.06.036

Atherosclerosis
Volume 212, Issue 2 , Pages 481-487 , October 2010

Article Tools

* Image Usage & Resolution